Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.72 USD | +2.83% | +2.85% | +3.30% |
Apr. 01 | JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating | MT |
Mar. 27 | Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.30% | 413M | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.50% | 29.48B | |
+57.29% | 25.43B | |
-18.01% | 11.49B | |
-44.02% | 11.3B | |
-15.61% | 11.1B | |
+4.19% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- ANNX Stock
- News Annexon, Inc.
- Transcript : Annexon, Inc. Presents at Needham 21st Annual Healthcare Conference, Apr-11-2022 03